Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $228.17 | 2 | 54.3% |
| Food and Beverage | $180.84 | 10 | 43.0% |
| Education | $11.07 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Foundation Medicine, Inc. | $228.17 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $103.87 | 6 | $0 (2021) |
| Exelixis Inc. | $31.54 | 2 | $0 (2017) |
| BTG International, Inc. | $21.22 | 1 | $0 (2017) |
| Genentech USA, Inc. | $20.65 | 1 | $0 (2018) |
| Seattle Genetics, Inc. | $14.63 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.07 | 1 | E.R. Squibb & Sons, L.L.C. ($11.07) |
| 2019 | $277.98 | 5 | Foundation Medicine, Inc. ($228.17) |
| 2018 | $39.71 | 2 | Genentech USA, Inc. ($20.65) |
| 2017 | $91.32 | 5 | Exelixis Inc. ($31.54) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2021 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $11.07 | General |
| Category: Hematology | ||||||
| 10/03/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $17.81 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $210.36 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Oncology | ||||||
| 03/19/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| 01/24/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| 01/23/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| 01/19/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: BioOncology | ||||||
| 12/08/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
| 10/26/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Oncology | ||||||
| 09/15/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Not Applicable | ||||||
| 05/12/2017 | BTG International, Inc. | VISTOGARD-20 (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: TOXICITY ANTIDOTE 5 FU TOXICITY | ||||||
| 01/20/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 388 | 787 | $317,406 | $58,975 |
| 2022 | 5 | 372 | 762 | $325,630 | $62,564 |
| 2021 | 8 | 469 | 895 | $387,176 | $76,070 |
| 2020 | 8 | 413 | 498 | $103,674 | $32,592 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 198 | 542 | $205,379 | $39,317 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 84 | $42,848 | $8,856 | 20.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 58 | 58 | $40,292 | $7,266 | 18.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 25 | $9,715 | $1,268 | 13.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 38 | $6,390 | $1,082 | 16.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 17 | 19 | $7,904 | $596.02 | 7.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 21 | $4,878 | $589.05 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 166 | 430 | $160,390 | $31,337 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 64 | 152 | $75,544 | $16,584 | 22.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 67 | 67 | $47,168 | $9,773 | 20.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 49 | 85 | $35,360 | $4,083 | 11.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 26 | 28 | $7,168 | $786.85 | 11.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 161 | 520 | $193,960 | $41,369 | 21.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 91 | 91 | $64,064 | $12,681 | 19.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 71 | 105 | $52,185 | $11,516 | 22.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 56 | 84 | $34,739 | $4,364 | 12.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 26 | 30 | $16,500 | $1,987 | 12.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $8,052 | $1,974 | 24.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 38 | 39 | $9,771 | $1,163 | 11.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $7,905 | $1,015 | 12.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 129 | $29,174 | $9,915 | 34.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 75 | 83 | $22,410 | $7,579 | 33.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 66 | 70 | $12,950 | $4,376 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 30 | 40 | $11,400 | $2,655 | 23.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 14 | 14 | $7,672 | $1,991 | 25.9% |
About Dr. Thomas Caughey, MD
Dr. Thomas Caughey, MD is a Hematology & Oncology healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063419398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Caughey, MD has received a total of $420.08 in payments from pharmaceutical and medical device companies, with $11.07 received in 2021. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program" ($228.17).
As a Medicare-enrolled provider, Caughey has provided services to 1,642 Medicare beneficiaries, totaling 2,942 services with total Medicare billing of $230,200. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Cambridge, MA
- Active Since 07/01/2005
- Last Updated 11/07/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1063419398
Products in Payments
- FOUNDATIONONE (Device) $228.17
- OPDIVO (Biological) $42.70
- Cabometyx (Drug) $31.54
- VISTOGARD-20 (Drug) $21.22
- Perjeta (Biological) $20.65
- ADCETRIS (Biological) $14.63
- Pomalyst (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cambridge
Robert Fram, M.d, M.D
Hematology & Oncology — Payments: $159,285
Jeffrey Jones, M.d, M.D
Hematology & Oncology — Payments: $20,956
Iris Sheng, M.d, M.D
Hematology & Oncology — Payments: $847.19
Debashish Misra, M.d, M.D
Hematology & Oncology — Payments: $456.08
Dr. Nabiel Alkhouri, M.d, M.D
Hematology & Oncology — Payments: $377.33
Anna Berkenblit, M.d, M.D
Hematology & Oncology — Payments: $67.56